Cargando…
High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
High density lipoproteins (HDLs) have a number of properties that have the potential to inhibit the development of atherosclerosis and thus reduce the risk of having a cardiovascular event. These protective effects of HDLs may be reduced in patients with type 2 diabetes, a condition in which the con...
Autor principal: | Barter, Philip J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811694/ https://www.ncbi.nlm.nih.gov/pubmed/24396675 http://dx.doi.org/10.3803/EnM.2013.28.3.169 |
Ejemplares similares
-
The Causes and Consequences of Low Levels of High Density Lipoproteins in Patients with Diabetes
por: Barter, Philip J.
Publicado: (2011) -
Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
por: Bonilha, Isabella, et al.
Publicado: (2021) -
High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity
por: Denimal, Damien, et al.
Publicado: (2023) -
High Density Lipoproteins and Diabetes
por: Cochran, Blake J., et al.
Publicado: (2021) -
High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)